...
首页> 外文期刊>Internal medicine. >A Case of Takayasu Arteritis with Repeated Coronary Artery Restenosis after Drug-Eluting Stent Implantation Successfully Treated with a Combination of Steroids
【24h】

A Case of Takayasu Arteritis with Repeated Coronary Artery Restenosis after Drug-Eluting Stent Implantation Successfully Treated with a Combination of Steroids

机译:联合类固醇成功治疗药物洗脱支架植入后高发性大动脉炎合并冠状动脉再狭窄的一例

获取原文
           

摘要

A 52-year-old woman with Takayasu arteritis developed acute coronary syndrome and received percutaneous coronary intervention (PCI). The patient experienced restenosis three times even with drug-eluting stent (DES) implantation. We started steroid administration after the fourth PCI to reduce inflammation due to autoimmunity. With DES and a steroid combination, the patient remained free of chest pain, and a follow-up angiography demonstrated good patency of the stent site. Since in-stent restenosis may result from a complicated combination of neointimal proliferation and autoimmune mechanisms, physicians should consider a combination of DES and a steroid for the treatment of coronary artery disease in Takayasu arteritis.
机译:一名52岁的Takayasu动脉炎妇女发展为急性冠状动脉综合征并接受了经皮冠状动脉介入治疗(PCI)。即使使用药物洗脱支架(DES)植入,患者也经历了3次再狭窄。我们在第四个PCI后开始类固醇给药,以减少由于自身免疫引起的炎症。结合使用DES和类固醇,患者无胸痛,并且后续的血管造影显示支架部位通畅。由于支架内再狭窄可能是由新内膜增生和自身免疫机制的复杂结合导致的,因此医师应考虑将DES和类固醇结合使用来治疗高津市大动脉炎的冠状动脉疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号